Startseite Proteomics of exhaled breath: methodological nuances and pitfalls
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Proteomics of exhaled breath: methodological nuances and pitfalls

  • Viktoria S. Kurova , Eldar C. Anaev , Alexey S. Kononikhin , Kristina Yu. Fedorchenko , Igor A. Popov , Timothey L. Kalupov , Dmitriy O. Bratanov , Eugenie N. Nikolaev und Sergey D. Varfolomeev
Veröffentlicht/Copyright: 1. Juni 2009
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: The analysis of exhaled breath condensate (EBC) can be an alternative to traditional endoscopic sampling of lower respiratory tract secretions. This is a simple non-invasive method of diagnosing respiratory diseases, in particular, respiratory inflammatory processes.

Methods: Samples were collected with a special device-condenser (ECoScreen, VIASYS Healthcare, Germany), then treated with trypsin according to the proteomics protocol for standard protein mixtures and analyzed by nanoflow high-performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS) with a 7-Tesla Finnigan LTQ-FT mass spectrometer (Thermo Electron, Germany). Mascot software (Matrixscience) was used for screening the database NCBInr for proteins corresponding to the peptide maps that were obtained.

Results: EBCs from 17 young healthy non-smoking donors were collected. Different methods for concentrating protein were compared in order to optimize EBC preparations for proteomic analysis. The procedure that was chosen allowed identification of proteins exhaled by healthy people. The major proteins in the condensates were cytoskeletal keratins. Another 12 proteins were identified in EBC from healthy non-smokers. Some keratins were found in the ambient air and may be considered exogenous components of exhaled air.

Conclusions: Knowledge of the normal proteome of exhaled breath allows one to look for biomarkers of different disease states in EBC. Proteins in ambient air can be identified in the respiratory tract and should be excluded from the analysis of the proteome of EBC. The results obtained allowed us to choose the most effective procedure of sample preparation when working with samples containing very low protein concentrations.

Clin Chem Lab Med 2009;47:706–12.


Corresponding author: Dr. Viktoria Kurova, N.M. Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, 4/11 Kosygin Street, 119334 Moscow, Russian Federation Fax: +7 495 137 41 01,

Received: 2008-11-26
Accepted: 2009-4-21
Published Online: 2009-06-01
Published in Print: 2009-06-01

©2009 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Editorial
  2. A focus on recent advances in proteomics – one step closer to entrance into the clinical arena
  3. Reviews
  4. Proteomics in protein misfolding diseases
  5. Multidimensional protein identification technology for clinical proteomic analysis
  6. Technical advances in proteomics mass spectrometry: identification of post-translational modifications
  7. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective
  8. Research Papers
  9. Thrombin induces broad spectrum proteolysis in human serum samples
  10. Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS)
  11. Proteomics of exhaled breath: methodological nuances and pitfalls
  12. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry
  13. Approaching clinical proteomics: current state and future fields of application in fluid proteomics
  14. Genetics and Molecular Diagnostics
  15. Detection of Hpdel in healthy individuals and cancer patients in Taiwan
  16. Increased CA 19-9 level in patients without malignant disease
  17. General Clinical Chemistry and Laboratory Medicine
  18. Quantitation of cerebrospinal fluid lactic acid in infectious and non-infectious neurological diseases
  19. Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study
  20. Reference Values and Biological Variations
  21. Influence of tourniquet application on venous blood sampling for serum chemistry, hematological parameters, leukocyte activation and erythrocyte mechanical properties
  22. Systemic cytokine response following exercise-induced muscle damage in humans
  23. Letters to the Editor
  24. CACNA1A gene non-synonymous single nucleotide polymorphisms and common migraine in Italy: a case-control association study with a micro-array technology
  25. Proficiency test of plasma free and total metanephrines: report from a study group
Heruntergeladen am 5.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.166/html
Button zum nach oben scrollen